Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
Earnings Data
Report Date
Jul 23, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
2.57Last Year’s EPS
2.35Same Quarter Last Year
Moderate Buy
Based on 16 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Apr 22, 2025
|% Change Since: 7.35%
|Next Earnings Date:Jul 23, 2025
Earnings Call Sentiment|Positive
The earnings call presented a positive outlook with strong revenue growth, successful partnerships, and strategic initiatives driving the business forward. However, there were some challenges, including impacts from weather, labor costs, and a strike affecting LifeLabs. Overall, the positive aspects outweighed the negatives, as evidenced by reaffirmed guidance and successful new product launches.Company Guidance
During the Quest Diagnostics First Quarter 2025 Conference Call, the company reported a robust 12% revenue growth, driven by nearly 2.5% organic growth as demand rebounded in March. Acquisitions and large enterprise accounts contributed to this growth, as did the demand for advanced diagnostics and expanded health plan access. The company's consolidated revenues for the quarter amounted to $2.65 billion, with Diagnostic Information Services revenue increasing by 12.7% year-over-year. Additionally, total volume grew by 12.4%, although organic volume experienced a slight decline of 0.9%. Reported operating income was $346 million, representing 13% of revenues, while adjusted operating income was $406 million, or 15.3% of revenues. Quest Diagnostics reaffirmed its full-year 2025 revenue guidance of $10.7 billion to $10.85 billion and adjusted EPS guidance of $9.55 to $9.80. The company also anticipates cash from operations to be approximately $1.5 billion and capital expenditures of about $500 million.Strong Revenue Growth
Consolidated revenues were $2.65 billion, up 12.1% compared to the prior year, with organic revenue growth of 2.4%.
Advanced Diagnostics Growth
Advanced diagnostics in key areas such as cardiometabolic, autoimmune, and brain health grew at double-digit rates.
Optum Health Partnership
Quest Diagnostics was named as the first independent national lab to be selected to the Optum Health preferred lab network.
Reaffirmed Guidance
Quest Diagnostics reaffirmed their revenue and adjusted EPS guidance for the full year 2025.
Operational Excellence Initiatives
The company continues to target 3% annual cost savings and productivity improvements through Invigorate and is also investing in Project Nova.
Successful Launch of Haystack MRD Test
Quest Diagnostics received commercial orders for their Haystack MRD test, which assesses early risk of cancer recurrence.
---
DGX Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
DGX Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Apr 22, 2025 | $161.86 | $172.84 | +6.78% |
| Jan 30, 2025 | $154.68 | $163.37 | +5.62% |
| Oct 22, 2024 | $145.94 | $155.94 | +6.85% |
| Jul 23, 2024 | $145.20 | $138.90 | -4.34% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Quest Diagnostics (DGX) report earnings?
Quest Diagnostics (DGX) is schdueled to report earning on Jul 23, 2025, TBA Not Confirmed.
What is Quest Diagnostics (DGX) earnings time?
Quest Diagnostics (DGX) earnings time is at Jul 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is DGX EPS forecast?
DGX EPS forecast for the fiscal quarter 2025 (Q2) is 2.57.
---